# A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses

> **NCT06136403** · PHASE2 · RECRUITING · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 10 (estimated)

## Conditions studied

- Epidermolysis Bullosa Simplex
- Ichthyosis
- Genodermatosis
- Inflammatory Congenital Ichthyoses

## Interventions

- **DRUG:** deucravacitinib

## Key facts

- **NCT ID:** NCT06136403
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-18
- **Primary completion:** 2025-09-30
- **Final completion:** 2026-10-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06136403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06136403, "A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT06136403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*